VANDELLI, Maria Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 40.156
EU - Europa 22.903
AS - Asia 18.644
SA - Sud America 2.469
Continente sconosciuto - Info sul continente non disponibili 523
AF - Africa 450
OC - Oceania 70
Totale 85.215
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 39.462
GB - Regno Unito 6.114
SE - Svezia 5.397
IT - Italia 5.360
CN - Cina 5.191
SG - Singapore 5.183
HK - Hong Kong 2.295
VN - Vietnam 1.847
BR - Brasile 1.818
DE - Germania 1.211
FI - Finlandia 829
TR - Turchia 813
BD - Bangladesh 805
UA - Ucraina 786
RU - Federazione Russa 774
FR - Francia 722
KR - Corea 621
IN - India 475
CA - Canada 349
BG - Bulgaria 308
NL - Olanda 260
AR - Argentina 208
ID - Indonesia 191
JP - Giappone 186
MX - Messico 171
IQ - Iraq 169
ZA - Sudafrica 148
IE - Irlanda 147
ES - Italia 134
PK - Pakistan 124
RO - Romania 124
PL - Polonia 121
EC - Ecuador 116
BE - Belgio 108
AE - Emirati Arabi Uniti 105
CO - Colombia 101
CH - Svizzera 76
MY - Malesia 76
LT - Lituania 66
VE - Venezuela 64
AU - Australia 61
IR - Iran 58
CL - Cile 57
PH - Filippine 57
AT - Austria 55
MA - Marocco 55
CZ - Repubblica Ceca 54
EG - Egitto 51
UZ - Uzbekistan 51
SA - Arabia Saudita 46
IL - Israele 43
TN - Tunisia 43
DZ - Algeria 37
LU - Lussemburgo 37
PY - Paraguay 37
PE - Perù 36
PT - Portogallo 35
TH - Thailandia 34
JM - Giamaica 33
NP - Nepal 33
TW - Taiwan 33
JO - Giordania 32
KE - Kenya 30
GR - Grecia 27
EU - Europa 23
CR - Costa Rica 22
AZ - Azerbaigian 21
KZ - Kazakistan 20
DK - Danimarca 18
DO - Repubblica Dominicana 18
ET - Etiopia 18
MD - Moldavia 17
TT - Trinidad e Tobago 17
UY - Uruguay 17
AL - Albania 16
HU - Ungheria 16
BO - Bolivia 14
LB - Libano 14
OM - Oman 14
RS - Serbia 14
SN - Senegal 14
BY - Bielorussia 12
KG - Kirghizistan 12
GT - Guatemala 11
HN - Honduras 11
NI - Nicaragua 11
NO - Norvegia 11
PR - Porto Rico 11
PA - Panama 10
SI - Slovenia 10
CY - Cipro 9
EE - Estonia 9
NZ - Nuova Zelanda 9
AM - Armenia 8
BH - Bahrain 8
HR - Croazia 8
KH - Cambogia 7
LA - Repubblica Popolare Democratica del Laos 7
LV - Lettonia 7
LY - Libia 7
Totale 84.561
Salva come PNG Salva come JPEG
Città #
Southend 4.606
Ashburn 3.826
Stockholm 3.594
Santa Clara 3.571
Singapore 3.213
Fairfield 2.822
Hong Kong 2.249
Chandler 2.167
Woodbridge 2.027
Hefei 1.715
Chicago 1.567
Jacksonville 1.535
Houston 1.428
San Jose 1.407
Seattle 1.201
Wilmington 1.172
Dearborn 1.131
Ann Arbor 1.073
Nyköping 1.028
Beijing 979
Los Angeles 962
Cambridge 957
London 785
Council Bluffs 696
Modena 651
Ho Chi Minh City 610
Seoul 529
Helsinki 521
The Dalles 463
Izmir 461
New York 449
Hanoi 428
Salt Lake City 395
Milan 392
Princeton 313
Dallas 305
Sofia 291
San Diego 271
Eugene 265
Rome 262
Buffalo 261
Lauterbourg 254
Bologna 220
Moscow 202
Des Moines 196
Shanghai 194
Redwood City 185
São Paulo 172
Tampa 168
Elk Grove Village 166
Munich 160
Orem 141
Columbus 135
Tokyo 134
Frankfurt am Main 127
Bremen 124
Phoenix 123
Jakarta 117
Dublin 116
Fremont 113
Boardman 99
Reggio Emilia 95
Brussels 93
Chennai 91
Lancaster 91
Guangzhou 87
Naples 87
Miami 84
Falls Church 81
Sterling 75
Atlanta 73
Johannesburg 73
Da Nang 71
Warsaw 71
Haiphong 69
Parma 68
Toronto 67
Washington 67
Montreal 62
Denver 59
Turin 59
Amsterdam 58
Baghdad 58
Brooklyn 57
Catania 54
Florence 54
Como 53
Dulles 53
Nanjing 53
Mexico City 52
Bari 51
Norwalk 50
Detroit 49
Mumbai 49
Turku 49
Kent 46
Miano 45
Tashkent 44
Kunming 42
Rio de Janeiro 42
Totale 58.206
Salva come PNG Salva come JPEG
Nome #
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 2.329
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.041
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 601
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 516
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 502
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 498
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 483
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 469
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 466
The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions 463
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 459
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 450
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 440
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 437
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 435
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 431
Cationic liposomes for gene transfection 425
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 424
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 423
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 422
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 421
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 420
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 418
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 412
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method 411
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 408
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 408
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 402
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 401
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 401
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 394
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 389
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 385
A Metabolomic Approach Applied to a LiquidChromatography Coupled to High-ResolutionTandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the ComprehensiveEvaluation of the Chemical Composition ofCannabis Medicinal Extracts 383
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 380
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 378
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 378
Polymeric nanoparticles for the drug delivery to the central nervous system 377
Nanoparticle transport across the blood brain barrier 372
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 370
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 370
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 370
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 368
Distribution of drugs in polymers loaded by swelling 365
Bead coating process via an excess of crosslinking agent 364
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 364
Brain targeting with polymeric nanoparticles: which administration route should we take? 363
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 363
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 360
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 360
Protein corona and nanoparticles: How can we investigate on? 358
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 356
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 350
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 350
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 348
Microwave-treated gelatin microspheres as drug delivery system 347
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 347
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 347
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 344
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 342
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 341
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 340
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 336
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 336
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 335
Pharmaceutical and biomedical analysis of cannabinoids: A critical review 335
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 334
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 334
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 333
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 332
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 332
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 331
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 331
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 331
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 328
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 328
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 327
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 327
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 327
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 326
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 325
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 325
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 323
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 322
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 321
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 320
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 319
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 319
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 318
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 316
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 316
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 316
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 312
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 311
Functionalization of liposomes: microscopical methods for preformulative screening 311
Colloidal systems for CNS drug delivery 308
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 307
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 307
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 304
Cis-Δ9-tetrahydrocannabinolic acid occurrence in Cannabis sativa L. 300
Totale 40.702
Salva come PNG Salva come JPEG
Categoria #
all - tutte 312.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 312.873
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.212 0 633 533 395 201 251 288 344 626 403 891 647
2022/20236.359 751 688 500 621 732 933 171 561 734 117 244 307
2023/20244.469 224 264 273 353 912 463 524 576 161 139 209 371
2024/202513.981 758 200 301 1.052 2.683 1.898 1.053 923 1.353 529 1.477 1.754
2025/202630.029 1.679 978 2.015 3.195 4.773 1.796 2.808 1.298 6.270 2.407 1.440 1.370
2026/20271.085 645 440 0 0 0 0 0 0 0 0 0 0
Totale 85.215